<SEC-DOCUMENT>0001437749-22-019187-index.html : 20220805
<SEC-HEADER>0001437749-22-019187.hdr.sgml : 20220805
<ACCEPTANCE-DATETIME>20220805162536
ACCESSION NUMBER:		0001437749-22-019187
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20220805
DATE AS OF CHANGE:		20220805
GROUP MEMBERS:		E&HEALTHCARE INVESTMENT FUND II
GROUP MEMBERS:		E&HEALTHCARE INVESTMENT FUND NO. 6
GROUP MEMBERS:		E&HEALTHCARE INVESTMENT FUND NO. 7
GROUP MEMBERS:		NA YEON KIM

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeuroBo Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89598
		FILM NUMBER:		221141198

	BUSINESS ADDRESS:	
		STREET 1:		200 BERKELEY ST.
		STREET 2:		FL 19
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		(857) 702-9600

	MAIL ADDRESS:	
		STREET 1:		200 BERKELEY ST.
		STREET 2:		FL 19
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gemphire Therapeutics Inc.
		DATE OF NAME CHANGE:	20150331

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			E&Investment, Inc.
		CENTRAL INDEX KEY:			0001796144
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		16TH FLOOR, YEOKSAM I-TOWER
		STREET 2:		B/D 326, TEHERAN-RO, GANGNAM-GU
		CITY:			SEOUL
		STATE:			M5
		ZIP:			00000
		BUSINESS PHONE:		82-2-501-3714

	MAIL ADDRESS:	
		STREET 1:		16TH FLOOR, YEOKSAM I-TOWER
		STREET 2:		B/D 326, TEHERAN-RO, GANGNAM-GU
		CITY:			SEOUL
		STATE:			M5
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>einv20220805_sc13da.htm
<DESCRIPTION>SCHEDULE 13D/A
<TEXT>
Document 1 - file: einv20220805_sc13da.htm

</DOCUMENT>
</SEC-DOCUMENT>